AbbVie Inc. (ABBV) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: $9.96B2018: $13.43B2019: $13.32B2020: $17.59B2021: $22.78B2022: $24.94B2023: $22.84B2024: $18.81B2025: $19.03B$19.03B
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$19.03B+1.2%
2024$18.81B-17.7%
2023$22.84B-8.4%
2022$24.94B+9.5%
2021$22.78B+29.5%
2020$17.59B+32.0%
2019$13.32B-0.8%
2018$13.43B+34.8%
2017$9.96B